Skip to main content

Advertisement

Log in

Array CGH technologies and their applications to cancer genomes

Chromosome Research Aims and scope Submit manuscript

Abstract

Cancer is a disease characterized by genomic instability. Comparative genomic hybridization (CGH) is a technique designed for detecting segmental genomic alterations. Recent advances in array-based CGH technology have enabled examination of chromosomal regions in unprecedented detail, revolutionizing our understanding of tumour genomes. A number of array-based technologies have been developed, aiming to improve the resolution of CGH, enabling researchers to refine and define regions in the genome that may be causal to cancer, and facilitating gene discovery at a rapid rate. This article reviews the various array CGH platforms and their use in the study of cancer genomes. In addition, the need for high-resolution analysis is discussed as well as the importance of studying early-stage disease to discover genetic alterations that may be causal to cancer progression and aetiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan J. Davies.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davies, J.J., Wilson, I.M. & Lam, W.L. Array CGH technologies and their applications to cancer genomes. Chromosome Res 13, 237–248 (2005). https://doi.org/10.1007/s10577-005-2168-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10577-005-2168-x

Key words

Navigation